Lincoln Pharmaceuticals ltd. — Board/Management Information 2021

Sep 30, 2021

==> picture [69 x 56] intentionally omitted <==

LINCOLN

PHARMACEUTICALS LIMITED

Date: September 30, 2021

HEALTHCARE FOR ALL

To, To, The Manager, Listing Department, The Department of Corporate Service, National Stock Exchange of India Limited, BSE Limited, Exchange Plaza, C - 1, Block - G, Bandra - 1[51] Floor, New Trading Ring, Rotunda Building, Phiroze Kurla Complex Bandra (E), Mumbai - 400 051. Jeejeebhoy Tower, Dalal Street, Mumbai - 400 001. Scrip Code - LINCOLN Scrip Code - 531633

Dear Sir,

Sub: Intimation under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

With reference to the above captioned subject, we would like to inform that the Meeting of the board of directors of the Company is scheduled to be held on Tuesday, October 05, 2021 at the Registered Office of the Company inter-alia to transact the following businesses:

• 1. To issue/ allot equity shares to the eligible shareholders of Lincoln Parenteral Ltd. pursuant to Scheme of Amalgamation of Lincoln Parenteral Limited ('Transferor Company') and Lincoln Pharmaceuticals Limited ('Transferee Company') and their respective shareholders and creditors, under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 as approved by the Hon'ble National Company Law Tribunal, Ahmedabad Bench vide its order dated September 14, 2021.
• 1. Any other item may be taken up for consideration with the permission of the Chairman and with the consent of a majority of the Directors present in the Meeting, if any.

Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and amendment thereto ("Regulations") and code of practices & procedures for fair disclosure of unpublished price sensitive information adopted by the Company, it is hereby informed that the trading window for dealing in the Company's securities shall remain closed from September 30, 2021 and shall reopen after the expiry of 48 hours from the announcement of financial results for the quarter ended on September 30, 2021 for Designated Persons viz. Directors, identified Employees, KMPs, Promoter and Promoter Group of the Company and its subsidiaries including Immediate Relatives of the Designated Persons of the Company and its subsidiaries and for the Connected Persons.

We request you to take the same on record.

Thanking you,

==> picture [197 x 107] intentionally omitted <==

----- Start of picture text ----- Yours faithfully,FOR LINCOLN,PHARMAC::;;E��::...:----- End of picture text -----

Regd. Office: "Ltncotn House", Science City Road, Sola, Ahmedabad-380 060. Gujarat, India Phone: +91-79-4107 8000 I Fax: +91-79-4107 8062 I CIN L24230GJ1995PLC024288 E-mail: info@lincolnpharma.com I Website: www.lincolnpharma.com

==> picture [46 x 48] intentionally omitted <==

==> picture [76 x 48] intentionally omitted <==

----- Start of picture text ----- lntertek ,,.----- End of picture text -----

Factory: 10 , 12, 13, Trimul Estate, Near Khatraj Chokadi, P.O. Khatraj-382721. Ta .: Kalal, Dist. Gandhinagar, [Guj.) I Phone: +91-79-49135000 I E-mail: khatraj@lincolnpharma.com